Fresenius Kabi Unveils 2026 Strategy With Focus On Business Not Region

Increased Focus On Biosimilars And Peptides Under New CEO Michael Sen

 
• By Dean Rudge
  
Fresenius Kabi
Kabi has grand plans under new CEO Michael Sen • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business